The question of life's origin on Earth continues to surprise. A new study challenges an old idea: that a chemical reaction ...

PALO ALTO, CA / ACCESS Newswire / May 30, 2025 / Riboscience, LLC, today announced the presentation of data from the completed dose escalation Phase 1a of the Phase 1a/b clinical trial of the ENPP1 ...

The FDA approved the poly ADP ribose polymerase (PARP) inhibitor in June 2023 in combination with enzalutamide for men with ...

Dr. Kristen Scarpato explains the role of genetic testing in prostate cancer care, as well as its use in determining ...

The bacteria that cause tuberculosis (TB) may have an "on-off switch" that lets them pause and restart growth, according to a ...

Former president Joe Biden has been diagnosed with prostate cancer, his office announced on Sunday. The 82-year-old has what ...

A new combination therapy that pairs a radiopharmaceutical (177Lu-DOTATATE) with a DNA-repair blocker (olaparib) has been ...

A surge of attention is sweeping through the wellness community as the newly redesigned Mitolyn.com unveils bold claims and ...

The bacteria that cause tuberculosis (TB) may have an "on-off switch" that lets them pause and restart growth, according to a new study from the University of Surrey and the University of Oxford.

The National Health Insurance Administration (NHIA) is to expand National Health Insurance (NHI) coverage to include two ...

Figure 2: Frequency distribution of telomere fluorescence shows telomere shortening associated with the lack of PARP. Figure 3: Lack of PARP does not affect the presence of single strand overhangs ...